Amivantamab and lazertinib in patients with EGFR-mutant non-small cell lung (NSCLC) after progression on osimertinib and platinum-based chemotherapy: Updated results from CHRYSALIS-2.

被引：0

作者：

Shu, Catherine A.

Goto, Koichi

Ohe, Yuichiro

Besse, Benjamin

Lee, Se-Hoon

Wang, Yongsheng

Griesinger, Frank

Yang, James Chih-Hsin

Felip, Enriqueta

Sanborn, Rachel E.

Caro, Reyes Bernabe

Curtin, Joshua C.

Chen, Jun

Mahoney, Janine M.

Trani, Leonardo

Bauml, Joshua Michael

Knoblauch, Roland Elmar

Thayu, Meena

Cho, Byoung Chul

机构：

[1] Columbia Univ, Med Ctr, New York, NY USA

[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr, Tokyo, Japan

[4] Paris Sacaly Univ, Inst Gustave Roussy, Villejuif, France

[5] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[6] Sichuan Univ, West China Hosp, Inst Clin Trial Ctr, Chengdu, Peoples R China

[7] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China

[8] Carl von Ossietzky Univ Oldenburg, Pius Hosp, Oldenburg, Germany

[9] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan

[10] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain

[11] Earle A Chiles Res Inst, Providence Canc Inst, Portland, OR USA

[12] Hosp Univ Virgen Rocio, Inst Biomed Seville, Seville, Spain

[13] Janssen R&D, Spring House, PA USA

[14] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9006

引用

页数：1

共 50 条

[1] Amivantamab plus lazertinib in post-osimertinib, post-platinum chemotherapy EGFR-mutant non-small cell lung cancer (NSCLC): Preliminary results from CHRYSALIS-2
Shu, C. A.
Goto, K.
Ohe, Y.
Besse, B.
Park, K.
Wang, Y.
Griesinger, F.
Yang, J. C-H.
Felip, E.
Sanborn, R. E.
Caro, R. Bernabe
Bauml, J. M.
Chen, J.
Fennema, E.
Mahoney, J.
Trani, L.
Knoblauch, R. E.
Thayu, M.
Cho, B. C.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S952 - S953
[2] Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2
Lee, S. -H.
Cho, B. C.
Spira, A. I.
Ou, S. -H. I.
Waqar, S. N.
Shah, S.
Trani, L.
Chu, P. -L.
Thayu, M.
Knoblauch, R. E.
Bauml, J. M.
Marmarelis, M. E.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S146 - S147
[3] Analysis of ctDNA next generation sequencing (NGS) for predicting response to amivantamab and lazertinib among patients with EGFR-mutant NSCLC after progression on osimertinib and platinum-based chemotherapy (CHRYSALIS-2 Cohort A)
Sanborn, Rachel E.
Waqar, Saiama N.
Cho, Byoung Chul
Besse, Benjamin
Goto, Koichi
Wang, Yongsheng
Lee, Se-Hoon
Marmarelis, Melina E.
Ohe, Yuichiro
Kim, Dong-Wan
Calles, Antonio
Neal, Joel
Baik, Christina S.
Janne, Pasi A.
Curtin, Joshua C.
Patel, Bharvin
Gormley, Mike
Shreeve, S. Martin
Bauml, Joshua M.
Knoblauch, Roland E.
[J]. CANCER RESEARCH, 2023, 83 (07)
[4] Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
Marmarelis, M. E.
Lee, S. -H.
Spira, A. I.
Ou, S. -H. I.
Waqar, S.
Li, S.
Thayu, M.
Knoblauch, R. E.
Bauml, J. M.
Cho, B. C.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S68 - S68
[5] Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Cho, B. C.
Lee, S. -H.
Han, J. -Y.
Cho, E. K.
Lee, J. -S.
Lee, K. H.
Curtin, J. C.
Gao, G.
Xie, J.
Schnepp, R. W.
Bauml, J. M.
Knoblauch, R. E.
Thayu, M.
Kim, D. -W.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S126 - S126
[6] Amivantamab plus lazertinib in atypical EGFR-mutated advanced non-small cell lung cancer (NSCLC): Results from CHRYSALIS-2
Cho, Byoung Chul
Wang, Yongsheng
Felip, Enriqueta
Cui, Jiuwei
Spira, Alexander I.
Neal, Joel W.
Baik, Christina
Marmarelis, Melina Elpi
Ichihara, Eiki
Lee, Jong-Seok
Lee, Se-Hoon
Yang, James Chih-Hsin
Michels, Sebastian Yves Friedrich
Anastasiou, Zacharias
Curtin, Joshua C.
Lyu, Xuesong
Leconte, Isabelle
Trani, Leonardo
Baig, Mahadi
Tomasini, Pascale
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[7] Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Moik, F.
Riedl, J. M.
Ay, C.
[J]. ANNALS OF ONCOLOGY, 2024, 35 (03) : 327 - 327
[8] Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
Cho, Byoung Chul
Kim, Dong-Wan
Spira, Alexander I.
Gomez, Jorge E.
Haura, Eric B.
Kim, Sang-We
Sanborn, Rachel E.
Cho, Eun Kyung
Lee, Ki Hyeong
Minchom, Anna
Lee, Jong-Seok
Han, Ji-Youn
Nagasaka, Misako
Sabari, Joshua K.
Ou, Sai-Hong Ignatius
Lorenzini, Patricia
Bauml, Joshua M.
Curtin, Joshua C.
Roshak, Amy
Gao, Grace
Xie, John
Thayu, Meena
Knoblauch, Roland E.
Park, Keunchil
[J]. NATURE MEDICINE, 2023, 29 (10) : 2577 - +
[9] Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Passaro, A.
Wang, J.
Wang, Y.
Lee, S. -H.
Melosky, B.
Shih, J. -Y.
Wang, J.
Azuma, K.
Juan-Vidal, O.
Cobo, M.
Felip, E.
Girard, N.
Cortot, A. B.
Califano, R.
Cappuzzo, F.
Owen, S.
Popat, S.
Tan, J. -l.
Salinas, J.
Tomasini, P.
Gentzler, R. D.
William, W. N.
Reckamp, K. L.
Takahashi, T.
Ganguly, S.
Kowalski, D. M.
Bearz, A.
MacKean, M.
Barala, P.
Bourla, A. B.
Girvin, A.
Greger, J.
Millington, D.
Withelder, M.
Xie, J.
Sun, T.
Shah, S.
Diorio, B.
Knoblauch, R. E.
Bauml, J. M.
Campelo, R. G.
Cho, B. C.
[J]. ANNALS OF ONCOLOGY, 2024, 35 (01) : 77 - 90
[10] Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
Byoung Chul Cho
Dong-Wan Kim
Alexander I. Spira
Jorge E. Gomez
Eric B. Haura
Sang-We Kim
Rachel E. Sanborn
Eun Kyung Cho
Ki Hyeong Lee
Anna Minchom
Jong-Seok Lee
Ji-Youn Han
Misako Nagasaka
Joshua K. Sabari
Sai-Hong Ignatius Ou
Patricia Lorenzini
Joshua M. Bauml
Joshua C. Curtin
Amy Roshak
Grace Gao
John Xie
Meena Thayu
Roland E. Knoblauch
Keunchil Park
[J]. Nature Medicine, 2023, 29 : 2577 - 2585

← 1 2 3 4 5 →